HIVE Digital Technologies Ltd. (NASDAQ:HIVE) price on Wednesday, May 09, remained unchanged to $2.27.
A look at the stock’s price movement, the close in the last trading session was $2.27. Turning to its 52-week performance, $6.84 and $2.27 were the 52-week high and 52-week low respectively. Overall, HIVE moved -25.82% over the past month.
HIVE Digital Technologies Ltd.’s market cap currently stands at around $237.44 million.
Analysts have a consensus estimate of 34.68M for the company’s revenue for the quarter, with a low and high estimate of 29.5M and 42.8M respectively. The average forecast suggests up to a 90.30% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 112.17M, representing a 5.50% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HIVE is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
HIVE’s current price about -17.21% and -26.37% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 26.65, while 7-day volatility ratio is 6.13% and 6.44% in the 30-day chart. Further, HIVE Digital Technologies Ltd. (HIVE) has a beta value of 3.78, and an average true range (ATR) of 0.18.
If we refocus on HIVE Digital Technologies Ltd. (NASDAQ:HIVE), historical trading data shows that trading volumes averaged 2.91 million over the past 3 months. The company’s latest data on shares outstanding shows there are 104.60 million shares.
The 0.49% of HIVE Digital Technologies Ltd.’s shares are in the hands of company insiders while institutional holders own 25.64% of the company’s shares. Current price change has pushed the stock -49.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HIVE stock continues to rise going into the next quarter.
